- ►juanncorpas.edu.co [PDF] DE DeWitt, IB Hirsch - Jama, 2003 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Newer insulin ... Cited by 273 - Related articles - BL Direct - All 8 versions
- ►endojournals.org I Pavo, G Jermendy, TT Varkonyi, Z Kerenyi, … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc Pioglitazone, a thiazolidinedione, improves glycemic control primarily by
increasing peripheral insulin sensitivity in patients with type 2 diabetes,
whereas metformin, a biguanide, exerts its effect primarily by decreasing ... Cited by 104 - Related articles - BL Direct - All 5 versions
- ►adisonline.com [PDF] M Rendell - Drugs, 2004 - ingentaconnect.com The sulphonylureas act by triggering insulin release from the pancreatic β
cell. Abstract A specific site on the adenosine triphosphate (ATP)-sensitive
potassium channels is occupied by sulphonylureas leading to closure of the ... Cited by 87 - Related articles - BL Direct - All 7 versions
- ►glucagon.com [PDF] - Free from Publisher MC Riddle, DJ Drucker - Diabetes Care, 2006 - Am Diabetes Assoc Current therapies for type 2 diabetes are frequently associated with inadequate
control of postprandial hyperglycemia, weight gain, and, in the case of oral
agents, loss of efficacy over time. A better understanding of physiological ... Cited by 71 - Related articles - BL Direct - All 10 versions
J Meece - The Diabetes Educator, 2006 - tde.sagepub.com The burden that diabetes has placed on the health care system as a result of
increased morbidity, mortality, and economic costs has continued to increase
with each new decade. A review of data from the Third National Health and ... Cited by 57 - Related articles - All 3 versions
- ►diabetesjournals.org SM Strowig, ML Avilés-Santa, P Raskin - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—HbA 1c levels decreased in both groups during dual therapy and
improved further during triple therapy (INS + MET 7.0 ± 0.8, INS + TGZ 6.2 ±
0.8, P < 0.0001; INS + MET, add TGZ 6.1 ± 0.4%, P < 0.001; INS + TGZ, add ... Cited by 49 - Related articles - BL Direct - All 5 versions
SM Setter, JL Iltz, J Thams, RK Campbell - Clinical therapeutics, 2003 - Elsevier Results: Metformin is the only currently available oral
antidiabetic/hypoglycemic agent that acts predominantly by inhibiting hepatic
glucose release. Because patients with type 2 diabetes often have excess ... Cited by 47 - Related articles - All 3 versions
JA Mayfield, RD White - American Family Physician, 2004 - teacherweb.com Pathophysiology of the Beta Cell Blood glucose is derived from carbohydrates
absorbed in the gut and produced in the liver. Absolute and increasing blood
glucose levels stimulate insulin release.2 The postprandial glucose influx ... Cited by 42 - Related articles - View as HTML - BL Direct - All 8 versions
V Mattoo, D Eckland, M Widel, S Duran, C … - Clinical therapeutics, 2005 - Elsevier This was a 6-month, randomized, double-blind, prospective, multicenter,
placebo-controlled, parallel-group study. Patients with type 2 DM and a
glycosylated hemoglobin (HbA 1c ) value ≥7.5% who were using insulin ... Cited by 40 - Related articles - All 4 versions
G Dailey - Clinical therapeutics, 2004 - Elsevier Results: Large-scale intervention trials, such as the United Kingdom Prospective
Diabetes Study (UKPDS), have reported that patients with type 2 DM treated with
oral combination therapy are unable to maintain glycemic control. These ... Cited by 34 - Related articles - All 4 versions
